Christopher Gregory Newton
Nessuna posizione attualmente
Storia della carriera di Christopher Gregory Newton
Precedenti posizioni note di Christopher Gregory Newton
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INVENTIVA | Direttore/Membro del Consiglio | - | 27/05/2019 |
| Independent Dir/Board Member | - | 27/05/2019 | |
| GALAPAGOS NV | Corporate Officer/Principal | 14/06/2010 | 14/12/2012 |
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | 01/01/2000 | 01/01/2005 |
| Fondatore | 01/01/2000 | 01/01/2005 | |
| Rhône-Poulenc, Inc. | Corporate Officer/Principal | 01/01/1979 | - |
| University of Essex | Corporate Officer/Principal | 01/01/1996 | 01/01/1999 |
| University of Warwick | Corporate Officer/Principal | 01/01/1994 | 01/01/1998 |
Cangenix Ltd.
 Cangenix Ltd. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., Cangenix Ltd. is a British pharmaceutical company that manufactures and develops pharmaceutical products. The company is based in Ashford, UK. Cangenix was acquired by Galapagos NV on January 15, 2013 for $2.31 million. | Direttore/Membro del Consiglio | - | - |
Biofocus, Inc.
 Biofocus, Inc. Pharmaceuticals: MajorHealth Technology Biofocus, Inc. operates as a clinical biotechnology company. The company is headquartered in the United Kingdom. | Direttore/Membro del Consiglio | - | - |
BioFocus DPI AG
 BioFocus DPI AG Miscellaneous Commercial ServicesCommercial Services BioFocus DPI AG provides research and development services. The private company is based in Allschwill, Switzerland and has subsidiaries in Germany. | Direttore/Membro del Consiglio | - | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Christopher Gregory Newton
| University of Cambridge | Undergraduate Degree |
| The University of Sheffield | Doctorate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 12 |
| Belgio | 2 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 7 |
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 6 |
| Commercial Services | 5 |
| Consumer Services | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| INVENTIVA | Health Technology |
| Aziende private | 9 |
|---|---|
Charles River Discovery Research Services UK Ltd.
 Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom. | Commercial Services |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
| Rhône-Poulenc, Inc. | Process Industries |
Biofocus, Inc.
Biofocus, Inc. Pharmaceuticals: MajorHealth Technology Biofocus, Inc. operates as a clinical biotechnology company. The company is headquartered in the United Kingdom. | Health Technology |
Argenta Discovery 2009 Ltd.
 Argenta Discovery 2009 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Argenta Discovery 2009 Ltd. offers contract research drug discovery services. The company is based in Margate, UK. | Commercial Services |
BioFocus DPI (Holdings) Ltd.
 BioFocus DPI (Holdings) Ltd. Financial ConglomeratesFinance Part of Charles River Laboratories International, Inc., BioFocus DPI (Holdings) Ltd. functions as an investment holding British company. The company is based in Margate, UK. | Finance |
Cangenix Ltd.
Cangenix Ltd. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., Cangenix Ltd. is a British pharmaceutical company that manufactures and develops pharmaceutical products. The company is based in Ashford, UK. Cangenix was acquired by Galapagos NV on January 15, 2013 for $2.31 million. | Health Technology |
BioFocus DPI AG
BioFocus DPI AG Miscellaneous Commercial ServicesCommercial Services BioFocus DPI AG provides research and development services. The private company is based in Allschwill, Switzerland and has subsidiaries in Germany. | Commercial Services |
